Drugs / HyperAcute-Prostate Cancer Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00105053 | Mar 2005 → Sep 2007 | prostate cancer | NewLink Genetics Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HyperAcute-Prostate Cancer Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00105053 ↗ |
| Modality | Vaccine | “a vaccine composed of irradiated allogeneic prostate cancer cell lines” NCT00105053 ↗ |